International Patent: DEPRESSION DISEASE MANAGEMENT SYSTEM BASED ON TARGETED METABOLOMICS AND MACHINE LEARNING MODEL

GENEVA, June 26 -- NANJING LIKANG PHARMACEUTICAL TECHNOLOGY CO., LTD. filed a patent application (CN2025/125047) for “DEPRESSION DISEASE MANAGEMENT SYSTEM BASED ON TARGETED METABOLOMICS AND MACHINE LEARNING MODEL”. With publication no. WO/2026/118650, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: G16H 50/70

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....